Hypoaldosteronism epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
In hospitalized patients the incidence rate of hypoaldosteronism is 3000 per 100,000 individuals. The prevalence rate of hypoaldosteronism in United states is 200,000 cases annually. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 16:45, 28 August 2017
|
Hypoaldosteronism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoaldosteronism epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hypoaldosteronism epidemiology and demographics |
|
Risk calculators and risk factors for Hypoaldosteronism epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
In hospitalized patients the incidence rate of hypoaldosteronism is 3000 per 100,000 individuals. The prevalence rate of hypoaldosteronism in United states is 200,000 cases annually.
Epidemiology and Demographics
Incidence
- The incidence of hypoaldosteronism in hospitalized patient is approximately 3000 per 100,000 individuals.[1]
Prevalence
- The prevalence of hypoaldosteronism is approximately 667 per 100,000 individuals.
- The prevalence of hypoaldosteronism is estimated to be 200,000 cases annually in the United States.
Age
- Hypoaldosteronism is most commonly seen in middle-aged and older individuals.
- Elderly patients on multiple drug therapy (polypharmacy) have an increased incidence of drug induced hypoaldosteronism.
- In younger patients, hypoaldosteronism is seen in patients with underlying diabetes mellitus type I or sickle cell disease.
Race
- Hypoaldosteronism is more prevalent in African-American, Native Americans, and Hispanics.
Gender
- Hypoaldosteronism affects both men and women equally.
References
- ↑ Haas CS, Pohlenz I, Lindner U, Muck PM, Arand J, Suefke S, Lehnert H (2013). "Renal tubular acidosis type IV in hyperkalaemic patients--a fairy tale or reality?". Clin. Endocrinol. (Oxf). 78 (5): 706–11. doi:10.1111/j.1365-2265.2012.04446.x. PMID 22891694.